The multifunctional receptor Lgr6 plays a key role in the regulation of tissue repair—a recent review outlines its broad scope from regenerative medicine to tumor prognosis.

A recent comprehensive review indicates that Lgr6, a member of the G protein-coupled receptor family, is becoming an important regulatory node in tissue homeostasis, damage repair, and disease progression. This protein is widely distributed in various tissues, including skin, kidneys, lungs, and intestines, and plays a crucial role in coordinating cellular behavior and maintaining homeostasis.

The review emphasizes that Lgr6 is one of the important biomarkers for stem cells and progenitor cells. It participates in cell growth, differentiation, and regeneration, playing a crucial role in normal development, especially organogenesis and damage repair. In the skin, Lgr6-positive cells are associated with wound healing and hair follicle regeneration; in the kidneys and lungs, they are involved in maintaining tissue structural integrity and repairing damaged tissue.

In terms of molecular mechanisms, Lgr6 exerts its effects by regulating key signaling pathways such as Wnt/β-catenin and PI3K/AKT. These pathways control cell proliferation, apoptosis, and migration, maintaining normal physiological functions and influencing disease progression. Lgr6's regulation of these processes makes it a crucial link between cell fate and pathological changes.

The review also reveals that Lgr6 plays a complex and dual role in disease. Abnormal Lgr6 expression has been observed in respiratory, digestive, cardiovascular, and reproductive system diseases, as well as in various cancers. It may influence tumor development, growth, and metastasis, and is associated with broader pathological processes such as inflammation and fibrosis.

Clinical relevance is also a focus. Changes in Lgr6 expression levels are associated with disease severity, patient prognosis, and treatment response. Particularly in cancer, elevated Lgr6 levels are often associated with disease progression and shortened survival, suggesting its potential as a prognostic indicator.

In regenerative medicine, Lgr6 is also considered a potential intervention target. The review points out its promising applications in wound repair, bone healing, and the treatment of degenerative diseases. However, Lgr6's dual role of promoting regeneration and driving disease means that relevant clinical strategies must be precise and context-dependent. 

Overall, Lgr6 is a versatile and far-reaching biological regulator. It is deeply involved in fundamental cellular processes and disease mechanisms, and its value as a diagnostic biomarker and potential therapeutic target is constantly increasing, opening new pathways for biomedical and medical innovation.